【摘要】

【摘要】目的 探讨经腹入路与经胸入路手术治疗贲门癌的近期疗效及预后影响。
方法 选取2011年1月至2018年1月我院收治的贲门癌患者50例，将其按照分配原则平均分为对照组和研究组，对照组应用经胸入路手术治疗，研究组应用经腹入路手术治疗，详细记录下两组患者的临床治疗效果以及预后的影响。
结果 治疗效果方面，研究组的近期治疗有效率高于对照组（P＜0.05）；围手术期相关指标方面，研究组患者的术中出血量明显少于对照组，研究组患者的手术时间、住院时间明显短于对照组患者，研究组的治疗效果好于对照组（P＜0.05）；预后影响方面，治疗前两组患者的症状的发生情况无明显差别（P＞0.05），在肺部感染、吻合口瘘及狭窄率、腹部感染等并发症方面，研究组患者的发生率明显低于对照组患者（P＜0.05）。
结论 在贲门癌的治疗过程当中应用经腹入路手术治疗，可以达到理想的治疗效果，可以缩短手术的时间，减少创伤，是一种理想的手术方式，临床上应当进一步推广应用。

【Abstract】

【Abstract】 Objective: Objective to investigate the effect of transabdominal approach and transthoracic approach in the treatment of cardiac cancer.
Methods:50 patients with cardiac cancer methods from January 2011 to January 2018 in our hospital, according to the distribution principle divided into the control group and the study group, the control group used the thoracic surgical treatment, the study group using transabdominal surgical treatment, effect of detailed records of the clinical curative effect of two groups of patients and the prognosis.
Results: the treatment effect, the study group the effective rate of treatment was higher than the control group (P < 0.05); the clinical symptoms, blood loss of patients in the study group were significantly less than the control group, the study group of patients with operation time, hospitalization time was significantly shorter than the control group, the study group has better therapeutic effect than the control group (P < 0.05); prognosis, there was no significant difference between the incidence of symptoms of patients in the two groups before treatment (P > 0.05), in pulmonary infection, anastomotic leakage and stenosis rate, abdominal infection and other complications, the incidence rate of patients was significantly lower than that of the control group (P < 0.05).
Conclusion  : the application of transabdominal approach in the treatment of gastric cardia cancer can achieve an ideal therapeutic effect. It can shorten the operation time and reduce trauma. It is an ideal surgical method and should be further applied in clinic.